Skip to content

China Biologic Products Holdings, Inc.: 10-Q filed 2013-08-06

What China Biologic Products Holdings, Inc. reported in its quarterly report filed 2013-08-06 (fiscal Q2 2013): 48 published measures, 136 facts as tagged in accession 0001144204-13-043313.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-06
Fiscal period
fiscal Q2 2013
Accession
0001144204-13-043313 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All China Biologic Products Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-30353,704,873USD
At 2012-12-31311,047,150USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-06-3049,927,651USD
At 2012-12-3153,627,986USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-30236,354,246USD
At 2012-12-31195,469,716USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-30147,264,448USD
At 2012-12-31129,609,317USD
At 2012-06-30104,487,225USD
At 2011-12-3189,411,835USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-3016,161,926USD91
2013-01-01 to 2013-06-3031,077,786USD181
2012-04-01 to 2012-06-3012,838,771USD91
2012-01-01 to 2012-06-3025,796,077USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-06-3037,908,728USD181
2012-01-01 to 2012-06-3032,069,232USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-06-3011,912,603USD181
2012-01-01 to 2012-06-305,098,533USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-04-01 to 2013-06-3053,580,523USD91
2013-01-01 to 2013-06-30107,612,255USD181
2012-04-01 to 2012-06-3050,466,339USD91
2012-01-01 to 2012-06-3097,693,800USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-10,610,765USD181
2012-01-01 to 2012-06-30-10,985,216USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-12,405,448USD181
2012-01-01 to 2012-06-30-6,688,540USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-06-30150,220,786USD
At 2012-12-31119,143,000USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-04-01 to 2013-06-3026,880,459shares91
2013-01-01 to 2013-06-3026,833,262shares181
2012-04-01 to 2012-06-3025,875,164shares91
2012-01-01 to 2012-06-3025,738,145shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-04-01 to 2013-06-3028,067,303shares91
2013-01-01 to 2013-06-3027,967,080shares181
2012-04-01 to 2012-06-3026,627,160shares91
2012-01-01 to 2012-06-3026,581,824shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-04-01 to 2013-06-300.6USD/shares91
2013-01-01 to 2013-06-301.15USD/shares181
2012-04-01 to 2012-06-300.5USD/shares91
2012-01-01 to 2012-06-301USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-04-01 to 2013-06-300.57USD/shares91
2013-01-01 to 2013-06-301.11USD/shares181
2012-04-01 to 2012-06-300.46USD/shares91
2012-01-01 to 2012-06-300.9USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-04-01 to 2013-06-303,745,649USD91
2013-01-01 to 2013-06-308,352,551USD181
2012-04-01 to 2012-06-303,333,616USD91
2012-01-01 to 2012-06-306,510,331USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-3062,337,422USD
At 2012-12-3151,325,177USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-06-303,047,962USD181
2012-01-01 to 2012-06-301,992,958USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-06-3025,315,313USD91
2013-01-01 to 2013-06-3051,293,705USD181
2012-04-01 to 2012-06-3021,308,347USD91
2012-01-01 to 2012-06-3040,137,592USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-30251,497,089USD
At 2012-12-31222,159,653USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-04-01 to 2013-06-30198,739USD91
2013-01-01 to 2013-06-30434,913USD181
2012-04-01 to 2012-06-30157,635USD91
2012-01-01 to 2012-06-30766,198USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-3043,544,150USD
At 2012-12-3147,719,092USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-06-303,018,095USD
At 2012-12-312,908,624USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-06-303,104,210USD
At 2012-12-313,541,582USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-06-3017,821,673USD
At 2012-12-3111,206,244USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-06-3080,907,813USD
At 2012-12-3175,679,173USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-3037,458,261USD91
2013-01-01 to 2013-06-3074,873,235USD181
2012-04-01 to 2012-06-3034,335,450USD91
2012-01-01 to 2012-06-3065,847,184USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-04-01 to 2013-06-3016,122,262USD91
2013-01-01 to 2013-06-3032,739,020USD181
2012-04-01 to 2012-06-3016,130,889USD91
2012-01-01 to 2012-06-3031,846,616USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-04-01 to 2013-06-30835,150USD91
2013-01-01 to 2013-06-301,748,242USD181
2012-04-01 to 2012-06-30929,489USD91
2012-01-01 to 2012-06-301,640,077USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3026,952,945shares
At 2012-12-3126,629,615shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3067,303,915USD
At 2012-12-3162,251,731USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-06-3018,826,850USD
At 2012-12-3114,072,322USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2013-06-30303,777,222USD
At 2012-12-31257,419,164USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-06-3065,587,420USD
At 2012-12-3161,322,144USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-06-3023,479,901USD
At 2012-12-3124,356,752USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-06-303,104,210USD
At 2012-12-313,541,582USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-303,410,801USD
At 2012-12-312,996,749USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2013-04-01 to 2013-06-3022,977,679USD91
2013-01-01 to 2013-06-3044,890,005USD181
2012-04-01 to 2012-06-3019,592,665USD91
2012-01-01 to 2012-06-3037,310,832USD182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-04-01 to 2013-06-3019,682,604USD91
2013-01-01 to 2013-06-3035,832,314USD181
2012-04-01 to 2012-06-3012,977,910USD91
2012-01-01 to 2012-06-3026,857,199USD182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-3016,076,699USD91
2013-01-01 to 2013-06-3030,920,171USD181
2012-04-01 to 2012-06-3012,838,771USD91
2012-01-01 to 2012-06-3025,796,077USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-308,866,071USD91
2013-01-01 to 2013-06-3017,553,168USD181
2012-04-01 to 2012-06-307,932,372USD91
2012-01-01 to 2012-06-3015,078,166USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,571,232USD91
2013-01-01 to 2013-06-303,105,739USD181
2012-04-01 to 2012-06-301,184,498USD91
2012-01-01 to 2012-06-302,281,223USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-04-01 to 2013-06-30391,452USD91
2013-01-01 to 2013-06-30655,152USD181
2012-04-01 to 2012-06-30733,794USD91
2012-01-01 to 2012-06-301,456,810USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,408,015USD91
2013-01-01 to 2013-06-301,948,851USD181
2012-04-01 to 2012-06-301,617,934USD91
2012-01-01 to 2012-06-303,683,571USD182

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-01-01 to 2013-06-30720,679USD181
2012-01-01 to 2012-06-3026,341USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-306,314,643USD181
2012-01-01 to 2012-06-304,692,006USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-303,616,165USD181
2012-01-01 to 2012-06-30-2,045,191USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30242,365USD181
2012-01-01 to 2012-06-30-1,546,373USD182

Inspect the source

Entity
China Biologic Products Holdings, Inc. / CIK 0001369868
Captured
SEC response SHA-256
b0858c70e7a3b91077c0e3df56721cd0deb1308061733593c5227aebcd4b73fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001369868.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))